Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study
Crossref DOI link: https://doi.org/10.1186/s12933-016-0350-4
Published Online: 2016-03-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ou, Huang-Tz
Chang, Kai-Cheng
Li, Chung-Yi
Wu, Jin-Shang
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (NSC 104-2320-B-006-008-MY3)
